BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15880639)

  • 1. Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer.
    Mireskandari S; Meiser B; Sherman K; Warner BJ; Andrews L; Tucker KM
    Psychooncology; 2006 Feb; 15(2):96-108. PubMed ID: 15880639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.
    Sherman KA; Kasparian NA; Mireskandari S
    Psychooncology; 2010 Jan; 19(1):1-11. PubMed ID: 19472298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
    Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five families living with hereditary breast and ovarian cancer risk.
    Norris J; Spelic SS; Snyder C; Tinley S
    Clin J Oncol Nurs; 2009 Feb; 13(1):73-80. PubMed ID: 19193551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups.
    Mellon S; Berry-Bobovski L; Gold R; Levin N; Tainsky MA
    Psychooncology; 2006 Mar; 15(3):193-208. PubMed ID: 16100704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy women from suspected hereditary breast and ovarian cancer families: the significant others in their lives.
    Kenen R; Arden-Jones A; Eeles R
    Eur J Cancer Care (Engl); 2004 May; 13(2):169-79. PubMed ID: 15115473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship satisfaction in women: a longitudinal case-control study about the role of breast cancer, personal assertiveness, and partners' relationship-focused coping.
    Hinnen C; Hagedoorn M; Ranchor AV; Sanderman R
    Br J Health Psychol; 2008 Nov; 13(Pt 4):737-54. PubMed ID: 17999780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of relationship adjustment among couples coping with a high risk of developing breast/ovarian cancer.
    Watts KJ; Sherman KA; Mireskandari S; Meiser B; Taylor A; Tucker K
    Psychol Health; 2011 May; 26 Suppl 1():21-39. PubMed ID: 20936567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the information flow: partners of women with breast cancer, patients, and healthcare professionals.
    Rees CE; Bath PA
    Oncol Nurs Forum; 2000 Sep; 27(8):1267-75. PubMed ID: 11013907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the quality of life and unmet needs of urban women with metastatic breast cancer.
    Aranda S; Schofield P; Weih L; Yates P; Milne D; Faulkner R; Voudouris N
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):211-22. PubMed ID: 15952965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
    Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
    Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-related relationship communication in couples coping with early stage breast cancer.
    Manne SL; Ostroff JS; Norton TR; Fox K; Goldstein L; Grana G
    Psychooncology; 2006 Mar; 15(3):234-47. PubMed ID: 15926198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.
    Suthers GK
    ANZ J Surg; 2007 May; 77(5):314-9. PubMed ID: 17497966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
    Swisher EM; Babb S; Whelan A; Mutch DG; Rader JS
    J Reprod Med; 2001 Feb; 46(2):87-94. PubMed ID: 11255821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative analysis of social concerns of women with ovarian cancer.
    Ferrell BR; Smith SL; Ervin KS; Itano J; Melancon C
    Psychooncology; 2003; 12(7):647-63. PubMed ID: 14502590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: implications for breast and ovarian cancer risk.
    Jernström H; Borg K; Olsson H
    Mol Genet Metab; 2005; 86(1-2):320-7. PubMed ID: 16084122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between coping strategies and anxiety in women from families with familial breast-ovarian cancer in the absence of demonstrated mutations.
    Geirdal AØ; Dahl AA
    Psychooncology; 2008 Jan; 17(1):49-57. PubMed ID: 17385192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.